Evidence map›Paper›PMID 32612064›Full record

ArticleInternal medicine (Tokyo, Japan)2020

The Quality of Life of Patients with Suspected Lung Cancer before and after Bronchoscopy and the Effect of Mirtazapine on the Depressive Status.

Yoshiko Kaneko, Takako Mouri, Yurie Seto, Naoya Nishioka, Akihiro Yoshimura, Chie Yamamoto, Sachi Harita, Yusuke Chihara, Nobuyo Tamiya, Tadaaki Yamada and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yoshiko KanekoDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Takako MouriDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Yurie SetoDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Naoya NishiokaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Akihiro YoshimuraDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Chie YamamotoDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Sachi HaritaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Yusuke ChiharaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Nobuyo TamiyaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Tadaaki YamadaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Junji UchinoDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Koichi TakayamaDepartment of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Japan.
Kyoto Prefectural University of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Patients with suspected lung cancer often experience adverse side effects such as anxiety, depression, and a decreased appetite. These side effects influence the patients' quality of life and their ability to make decisions concerning appropriate treatment. This study examined the psychological status and quality of life of patients with suspected lung cancer before and after bronchoscopy treatment and evaluated the effect of mirtazapine prescribed to patients with depression. Methods To assess patient characteristics (e.g. age, gender, and medical history), a questionnaire including the Hospital Anxiety and Depression Scale - Japanese version and the Functional Assessment of Cancer Therapy-L was administered. Patients Forty-three patients admitted for bronchoscopy treatment between May 2017 and April 2018 were included. Results The results showed that patients with depression reported a worse quality of life than those without depression. Compared with no medication, the administration of mirtazapine alleviated depressive symptoms. Furthermore, the patients' depressive status was affected by their physical symptoms, including coughing, tightness of chest, and dyspnea. Conclusion Our results emphasize the importance of detecting depression in the early stages of a cancer diagnosis and have significant implications concerning pharmacological intervention in patients with cancer displaying signs of depression.

Indexed as

Quality of LifeAdultAgedAntidepressive AgentsBronchoscopyDepressionFemaleHumansLung NeoplasmsMaleMiddle AgedMirtazapineSurveys and QuestionnairesAntidepressive AgentsMirtazapinebronchoscopydepressionlung cancermirtazapinequality of life

Identifiers

PMID32612064
PMCPMC7402957
OpenAlexW3040620211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.